✦ LIBER ✦

Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma

✍ Scribed by David M. Loeb; Elizabeth Garrett-Mayer; Robert F. Hobbs; Andrew R. Prideaux; George Sgouros; Ori Shokek; Moody D. Wharam Jr; Tammy Scott; Cindy L. Schwartz

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 153 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24286

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II study of 153Sm-EDTMP and high

A Phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

✍ Angela Dispenzieri; Gregory A. Wiseman; Martha Q. Lacy; Suzanne R. Hayman; Shaji 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Combined use of zoledronic acid and 153S

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases

✍ Marnix G. E. H. Lam; Amel Dahmane; Wil H. M. Stevens; Peter P. van Rijk; John M. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 243 KB

Clinical benefit of bone-targeted radiom

Clinical benefit of bone-targeted radiometabolic therapy with153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer

✍ Sergio Ricci; Giuseppe Boni; Ilaria Pastina; Dario Genovesi; Claudia Cianci; Ser 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 160 KB

A double-blind dose-finding study of rol

A double-blind dose-finding study of rolipram in patients with major depressive disorder

✍ E. H. Bennie; S. K. Chakravarti; C. M. B. Jarman; K. Khan; D. Master; G. H. Murr 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 2 views

Rolipram improves signal transmission in central noradrenergic neurones with a novel mechanism of action: enhanced noradrenaline (first messenger) synthesis and release, and inhibition of cAMP (second messenger) breakdown. Several comparative trials to prove antidepressant activity are under way. Re

A dose-finding study of lanreotide (A so

A dose-finding study of lanreotide (A somatostatin analog) in patients with colorectal carcinoma

✍ Angelo Di Leo; Emilio Bajetta; Leonardo Ferrari; Laura Biganzoli; Luigi Mariani; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 708 KB

## Background: Laboratory data suggest that insulin-like growth factor-1 (igf-1) may stimulate the growth of different human tumors. at least in acromegalic patients, somatostatin (sms) analogs, such as lanreotide, suppress the serum levels of growth hormone (gh) and igf-1. ## Methods: To evaluat

A phase II study of cisplatin, doxorubic

A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis

✍ Shreyaskumar R. Patel; Nicholas Papadopolous; A. Kevin Raymond; Michele Donato; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

## Abstract ## BACKGROUND The authors evaluated the efficacy and toxicity of cisplatin, ifosfamide, and doxorubicin with peripheral blood stem cell (PBSC) support in adult patients with osteosarcomas and variants with a poor prognosis. ## METHODS Between December 1994 and January 2001, 37 patien